Advertisement
HOUSTON, May 3, 2019 /PRNewswire-PRWeb/ -- OrthoAccel® Technologies, Inc. announced today a $20.5 Million debt and equity financing from its lead investor, S3 Ventures. OrthoAccel manufactures and sells AcceleDent Optima, an innovative medical device that builds a better orthodontic experience. By making complex cases less complex, AcceleDent Optima improves the predictability of clinical outcomes while dramatically accelerating treatment times and reducing pain and discomfort.
"We remain excited about OrthoAccel's global market opportunity and AcceleDent Optima's position as the market leader of the accelerated orthodontic category," said Brian R. Smith, managing director of S3 Ventures. "AcceleDent is proven effective and is backed by 15 clinical studies with three randomized clinical trials completed. We are seeing an increased adoption in best-in-class orthodontic practices globally, with over 100,000 patient case starts across 3,000+ providers. We remain committed to driving future, profitable growth."
Smith adds that the OrthoAccel team is looking forward to connecting with doctors and their clinical teams at the 2019 American Association of Orthodontics Annual Session, May 3- 7. (Booth 325).
"We are excited to see the adoption of AcceleDent Optima increasing dramatically with our existing and new providers. In particular, we are increasingly working with more aligner focused orthodontic practices," said Todd Cooper, president and CEO of OrthoAccel. "With the introduction of many new aligners available globally, both OrthoAccel and orthodontic practices utilizing aligner therapy will benefit from patients who want the most advanced and effective treatment options."
For more information about OrthoAccel, visit AcceleDent.com.
About OrthoAccel® Technologies, Inc. OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company's innovations is AcceleDent®, an FDA-cleared, Class II medical device that employs patented SoftPulse Technology® that is clinically proven to speed up bone remodeling during orthodontic treatment by enhancing physiological bone turnover. These safe and gentle vibrations accelerate tooth movement by as much as 50 percent and reduce discomfort associated with treatment. OrthoAccel, the Leader in Accelerated Orthodontics, has received positive feedback from patients and leading orthodontists from around the world who report increased mechanical efficiency with orthodontic appliances and improved predictability of clinical outcomes with AcceleDent. OrthoAccel is based in Houston, Texas and maintains a global presence through its office in Essen, Germany. To learn more about OrthoAccel's focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.
SOURCE OrthoAccel® Technologies, Inc.
Advertisement
"We remain excited about OrthoAccel's global market opportunity and AcceleDent Optima's position as the market leader of the accelerated orthodontic category," said Brian R. Smith, managing director of S3 Ventures. "AcceleDent is proven effective and is backed by 15 clinical studies with three randomized clinical trials completed. We are seeing an increased adoption in best-in-class orthodontic practices globally, with over 100,000 patient case starts across 3,000+ providers. We remain committed to driving future, profitable growth."
Smith adds that the OrthoAccel team is looking forward to connecting with doctors and their clinical teams at the 2019 American Association of Orthodontics Annual Session, May 3- 7. (Booth 325).
"We are excited to see the adoption of AcceleDent Optima increasing dramatically with our existing and new providers. In particular, we are increasingly working with more aligner focused orthodontic practices," said Todd Cooper, president and CEO of OrthoAccel. "With the introduction of many new aligners available globally, both OrthoAccel and orthodontic practices utilizing aligner therapy will benefit from patients who want the most advanced and effective treatment options."
For more information about OrthoAccel, visit AcceleDent.com.
About OrthoAccel® Technologies, Inc. OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company's innovations is AcceleDent®, an FDA-cleared, Class II medical device that employs patented SoftPulse Technology® that is clinically proven to speed up bone remodeling during orthodontic treatment by enhancing physiological bone turnover. These safe and gentle vibrations accelerate tooth movement by as much as 50 percent and reduce discomfort associated with treatment. OrthoAccel, the Leader in Accelerated Orthodontics, has received positive feedback from patients and leading orthodontists from around the world who report increased mechanical efficiency with orthodontic appliances and improved predictability of clinical outcomes with AcceleDent. OrthoAccel is based in Houston, Texas and maintains a global presence through its office in Essen, Germany. To learn more about OrthoAccel's focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.
SOURCE OrthoAccel® Technologies, Inc.
